ICICI Prudential US Bluechip Equity Fund Regular Growth
EquityGlobal - OtherVery High Risk
Regular
NAV (17-Jun-25)
Returns (Since Inception)
Fund Overview
Fund Size
₹3,015 Cr
Expense Ratio
2.03%
ISIN
INF109K01E35
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
06 Jul 2012
About this fund
As of 17-Jun-25, it has a Net Asset Value (NAV) of ₹61.45, Assets Under Management (AUM) of 3015.47 Crores, and an expense ratio of 2.03%.
- ICICI Prudential US Bluechip Equity Fund Regular Growth has given a CAGR return of 15.05% since inception.
- The fund's asset allocation comprises around 98.01% in equities, 0.00% in debts, and 1.99% in cash & cash equivalents.
- You can start investing in ICICI Prudential US Bluechip Equity Fund Regular Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.
Performance against Category Average
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+7.67%
— (Cat Avg.)
3 Years
+16.27%
— (Cat Avg.)
5 Years
+12.69%
— (Cat Avg.)
10 Years
+13.08%
— (Cat Avg.)
Since Inception
+15.05%
— (Cat Avg.)
Portfolio Summaryas of 31st May 2025
| Equity | ₹2,955.52 Cr | 98.01% |
| Others | ₹59.95 Cr | 1.99% |
Top Holdings
All Holdings
Equity
Debt & Others
| Name | Type  | Amount | Holdings |
|---|---|---|---|
| Veeva Systems Inc Class A | Equity | ₹91.55 Cr | 3.04% |
| West Pharmaceutical Services Inc | Equity | ₹84.71 Cr | 2.81% |
| Huntington Ingalls Industries Inc | Equity | ₹80.85 Cr | 2.68% |
| Brown-Forman Corp Registered Shs -B- Non Vtg | Equity | ₹80.25 Cr | 2.66% |
| Allegion PLC | Equity | ₹74.39 Cr | 2.47% |
| Zimmer Biomet Holdings Inc | Equity | ₹74.06 Cr | 2.46% |
| Microchip Technology Inc | Equity | ₹73.43 Cr | 2.44% |
| Pfizer Inc | Equity | ₹72.88 Cr | 2.42% |
| Monolithic Power Systems Inc | Equity | ₹72.86 Cr | 2.42% |
| Corteva Inc | Equity | ₹72.53 Cr | 2.41% |
| GE HealthCare Technologies Inc Common Stock | Equity | ₹72.48 Cr | 2.40% |
| The Campbell's Co | Equity | ₹72.46 Cr | 2.40% |
| U.S. Bancorp | Equity | ₹72.29 Cr | 2.40% |
| The Walt Disney Co | Equity | ₹71.09 Cr | 2.36% |
| Boeing Co | Equity | ₹71.03 Cr | 2.36% |
| MarketAxess Holdings Inc | Equity | ₹70.09 Cr | 2.32% |
| Alphabet Inc Class C | Equity | ₹67.93 Cr | 2.25% |
| Nike Inc Class B | Equity | ₹67.11 Cr | 2.23% |
| Adobe Inc | Equity | ₹66.52 Cr | 2.21% |
| Agilent Technologies Inc | Equity | ₹66.52 Cr | 2.21% |
| The Estee Lauder Companies Inc Class A | Equity | ₹66.01 Cr | 2.19% |
| Danaher Corp | Equity | ₹64.93 Cr | 2.15% |
| NXP Semiconductors NV | Equity | ₹63.39 Cr | 2.10% |
| International Flavors & Fragrances Inc | Equity | ₹63.14 Cr | 2.09% |
| TransUnion | Equity | ₹61.33 Cr | 2.03% |
| Constellation Brands Inc Class A | Equity | ₹61.11 Cr | 2.03% |
| United Parcel Service Inc Class B | Equity | ₹60.53 Cr | 2.01% |
| Bio-Rad Laboratories Inc Class A | Equity | ₹54.93 Cr | 1.82% |
| Net Current Assets | Cash | ₹43.98 Cr | 1.46% |
| Microsoft Corp | Equity | ₹43.67 Cr | 1.45% |
| Mondelez International Inc Class A | Equity | ₹43.27 Cr | 1.43% |
| Amgen Inc | Equity | ₹41.88 Cr | 1.39% |
| Charles Schwab Corp | Equity | ₹41.59 Cr | 1.38% |
| Synopsys Inc | Equity | ₹41.25 Cr | 1.37% |
| Oracle Corp | Equity | ₹40.51 Cr | 1.34% |
| Bristol-Myers Squibb Co | Equity | ₹40.38 Cr | 1.34% |
| Thermo Fisher Scientific Inc | Equity | ₹40.35 Cr | 1.34% |
| Amazon.com Inc | Equity | ₹39.95 Cr | 1.32% |
| Merck & Co Inc | Equity | ₹39.93 Cr | 1.32% |
| Manhattan Associates Inc | Equity | ₹39.09 Cr | 1.30% |
| Northrop Grumman Corp | Equity | ₹38.37 Cr | 1.27% |
| Equifax Inc | Equity | ₹37.92 Cr | 1.26% |
| Lam Research Corp | Equity | ₹37.1 Cr | 1.23% |
| Gilead Sciences Inc | Equity | ₹34.74 Cr | 1.15% |
| Masco Corp | Equity | ₹32.26 Cr | 1.07% |
| Applied Materials Inc | Equity | ₹32.16 Cr | 1.07% |
| Autodesk Inc | Equity | ₹31.83 Cr | 1.06% |
| Biogen Inc | Equity | ₹29.24 Cr | 0.97% |
| Cadence Design Systems Inc | Equity | ₹28.45 Cr | 0.94% |
| Kenvue Inc | Equity | ₹26.54 Cr | 0.88% |
| Teradyne Inc | Equity | ₹26.01 Cr | 0.86% |
| Comcast Corp Class A | Equity | ₹25.95 Cr | 0.86% |
| IDEX Corp | Equity | ₹23.72 Cr | 0.79% |
| Salesforce Inc | Equity | ₹21.42 Cr | 0.71% |
| Occidental Petroleum Corp | Equity | ₹16.66 Cr | 0.55% |
| EPAM Systems Inc | Equity | ₹16.66 Cr | 0.55% |
| Qualcomm Inc | Equity | ₹16.59 Cr | 0.55% |
| Freeport-McMoRan Inc | Equity | ₹16.23 Cr | 0.54% |
| Treps | Cash - Repurchase Agreement | ₹15.97 Cr | 0.53% |
| Medtronic PLC | Equity | ₹12.02 Cr | 0.40% |
| ASML Holding NV ADR | Equity | ₹10.08 Cr | 0.33% |
| Altria Group Inc | Equity | ₹10.04 Cr | 0.33% |
| Yum China Holdings Inc | Equity | ₹9.28 Cr | 0.31% |
Other Allocation
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Healthcare | ₹820.58 Cr | 27.21% |
| Technology | ₹661.01 Cr | 21.92% |
| Industrials | ₹419.07 Cr | 13.90% |
| Consumer Defensive | ₹359.68 Cr | 11.93% |
| Financial Services | ₹245.3 Cr | 8.13% |
| Communication Services | ₹164.97 Cr | 5.47% |
| Basic Materials | ₹151.89 Cr | 5.04% |
| Consumer Cyclical | ₹116.34 Cr | 3.86% |
| Energy | ₹16.66 Cr | 0.55% |
Risk & Performance Ratios
Standard Deviation
This fund
18.31%
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
0.35
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Fund Managers
Ritesh Lunawat
Since September 2024
Sharmila D’mello
Since July 2022
Nitya Mishra
Since November 2024
Additional Scheme Detailsas of 31st May 2025
ISIN | INF109K01E35 | Expense Ratio | 2.03% | Exit Load | 1.00% | Fund Size | ₹3,015 Cr | Age | 12 years 11 months | Lumpsum Minimum | ₹5,000 | Fund Status | Open Ended Investment Company | Benchmark | S&P 500 TR USD |
Investment Objective
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Tax Treatment
Capital Gains Taxation:
- If units are sold after 1 year from the date of investment: Gains up to INR 1.25 lakh in a financial year are exempt from tax. Any gains exceeding INR 1.25 lakh are taxed at a rate of 12.5%.
- If units are sold within 1 year from the date of investment: The entire amount of gain is taxed at a rate of 20%.
- Holding the units: No tax is applicable as long as you continue to hold the units.
Dividend Taxation:
Dividends are added to the investor’s income and taxed according to their respective tax slabs. Additionally, if an investors dividend income exceeds INR 5,000 in a financial year, the fund house deducts a 10% Tax Deducted at Source (TDS) before distributing the dividend.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Similar Global - Other Funds
About the AMC
Total AUM
₹9,45,300 Cr
Address
3rd Floor, Hallmark Business Plaza, Mumbai, 400 051
Other Funds by ICICI Prudential Mutual Fund
Risk Level
Your principal amount will be at Very High Risk
Unlock Expert Insights!
Related Articles
Still got questions?
We're here to help.
What is the current NAV of ICICI Prudential US Bluechip Equity Fund Regular Growth?
What are the returns of ICICI Prudential US Bluechip Equity Fund Regular Growth?
What is the portfolio composition of ICICI Prudential US Bluechip Equity Fund Regular Growth?
Who manages the ICICI Prudential US Bluechip Equity Fund Regular Growth?
- Ritesh Lunawat
- Sharmila D’mello
- Nitya Mishra
Dezerv Investments Private Limited is a Portfolio Manager with SEBI Registration no. INP000007377 and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.
Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.